The most effective drug for Alzheimer’s has been blocked for use on the NHS. Regulators have declared the new treatment for ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

A new drug that slows the pace of Alzheimer's disease is too expensive for too little benefit to be used on the NHS, the ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...

A new pioneering Alzheimer's drug has been rejected for widespread use in the NHS in England. The announcement comes as the ...

A drug that can slow the progression of Alzheimer's disease has been blocked for use on the NHS due to cost concerns.

A pioneering new drug, which has been shown to slow the advance of Alzheimer's, will not be available to patients on the NHS as Ian Woods reports. A new "effective" Alzheimer's drug has been rejected ...

The U.K. watchdog declines to endorse Eli Lilly's Alzheimer's drug donanemab, citing lack of value for the NHS and ...

A new Alzheimer’s drug has been rejected by the health spending watchdog for general use within NHS England, with the ...